The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Dhanashree S. Kelkar, Mustafa A. Bharbuiya, Pamela L. Rojas, Vered Stearns, Edward Gabrielson, Pavani Malla, Saraswati Sukumar, Nupam P. Mahajan, Akhilesh Pandey

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint Dive into the research topics of 'The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences